Gout is treatable and most common inflammatory type of arthritis which is caused by deposition of Monosodium Urate Crystals (MUS) it occurs in articular, non-articular and specially in joint. Gout which is identified by condition-Hyperuricemia (increased serum urate ). Gout also characterized by Chronic Metabolic Disease, and Chronic gout disease is characterized by 4 distinct stages-Asymptomatic Hyperuricemia, Acute gout attack, Intercritical period, Chronic tophaceous gout. In this case long-term urate lowering therapy (Allopurinol) is mostly used and also the use of NSAIDs, Corticosteroid, Colchicine, Gluco-corticoids, etc.are use to reduce inflammation and relieve pain. Urate lowering therapies, Xanthine oxidase inhibitors are also used to treat the Established gout. Genetic metabolic and environment factor can influence this condition. Diagnosis of gout affecting the hip joint posses significant challenges. Risk factor of gout are age, sex, genetic factor, and medication. The Comorbidities associated with gout includes Cardiovascular disease, Liver disease, Chronic kidney disease, Diabetes and infection. The adverse effects of gout includes the vomiting, myalgia, neuropathy, stomach pain, etc. The review aims to understand the epidemiology, pathology, risk factor, management or treatment
Yalsangi. et al. (Sun,) studied this question.